Assessment of the Risk of Nodal Involvement in Rectal Neuroendocrine Neoplasms: The NOVARA Score, a Multicentre Retrospective Study.

endoscopic mucosal resection endoscopic submucosal dissection low anterior resection lymph node metastasis rectal neuroendocrine tumor

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
28 Jan 2022
Historique:
received: 30 12 2021
revised: 25 01 2022
accepted: 26 01 2022
entrez: 15 2 2022
pubmed: 16 2 2022
medline: 16 2 2022
Statut: epublish

Résumé

Rectal neuroendocrine tumors (r-NETs) are rare tumors with overall good prognosis after complete resection. However, there is no consensus on the extension of lymphadenectomy or regarding contraindications to extensive resection. In this study, we aim to identify predictive factors that correlate with nodal metastasis in patients affected by G1-G2 r-NETs. A retrospective analysis of G1-G2 r-NETs patients from eight tertiary Italian centers was performed. From January 1990 to January 2020, 210 patients were considered and 199 were included in the analysis. The data for nodal status were available for 159 cases. The nodal involvement rate was 9%. A receiver operating characteristic (ROC) curve analysis was performed to identify the diameter (>11.5 mm) and Ki-67 (3.5%), respectively, as cutoff values to predict nodal involvement. In a multivariate analysis, diameter > 11.5 mm and vascular infiltration were independently correlated with nodal involvement. A risk scoring system was constructed using these two predictive factors. Tumor size and vascular invasion are predictors of nodal involvement. In addition, tumor size > 11.5 mm is used as a driving parameter of better-tailored treatment during pre-operative assessment. Data from prospective studies are needed to validate these results and to guide decision-making in r-NETs patients in clinical practice.

Identifiants

pubmed: 35160165
pii: jcm11030713
doi: 10.3390/jcm11030713
pmc: PMC8836953
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Surg Oncol. 2021 Dec;124(7):1098-1105
pubmed: 34291822
Gut. 2007 Jun;56(6):863-8
pubmed: 17213340
J Gastrointest Surg. 2017 Dec;21(12):2066-2074
pubmed: 29047070
Neuroendocrinology. 2013;98(3):180-7
pubmed: 24080744
Cancer Treat Rev. 2018 May;66:45-55
pubmed: 29684743
Sci Rep. 2021 Apr 12;11(1):7881
pubmed: 33846396
Eur J Surg Oncol. 2021 Dec;47(12):3166-3174
pubmed: 34294465
Hum Pathol. 2020 Oct;104:66-72
pubmed: 32763255
Clin Endosc. 2017 Nov;50(6):530-536
pubmed: 29207857
Ann Oncol. 2012 Oct;23(10):2479-2516
pubmed: 23012255
J Gastrointest Surg. 2012 Mar;16(3):595-602
pubmed: 22143420
J Surg Oncol. 2019 Nov;120(6):932-939
pubmed: 31448820
Surg Endosc. 2016 Oct;30(10):4239-48
pubmed: 26718357
Pathol Res Pract. 2019 Nov;215(11):152642
pubmed: 31585816
JAMA Oncol. 2017 Oct 1;3(10):1335-1342
pubmed: 28448665
Ann Gastroenterol Surg. 2020 Jun 10;4(5):562-570
pubmed: 33005851
Diagnostics (Basel). 2021 Apr 25;11(5):
pubmed: 33923121
Surg Endosc. 2021 May 19;:
pubmed: 34009477
Gastrointest Endosc. 2019 Mar;89(3):602-606
pubmed: 30447216
Sci Rep. 2019 Mar 20;9(1):4911
pubmed: 30894571
Neuroendocrinology. 2012;95(2):88-97
pubmed: 22261972
Ann Gastroenterol Surg. 2020 Nov 17;5(2):215-220
pubmed: 33860141
Endocrine. 2019 Jul;65(1):207-212
pubmed: 30919286
Gut Liver. 2021 Sep 24;:
pubmed: 34552040
World J Gastroenterol. 2016 Nov 14;22(42):9400-9410
pubmed: 27895428
J Natl Compr Canc Netw. 2021 Jul 28;19(7):839-868
pubmed: 34340212
Cancer. 2003 Feb 15;97(4):934-59
pubmed: 12569593
Virchows Arch. 2007 Oct;451(4):757-62
pubmed: 17674042
Neuroendocrinology. 2016;103(2):139-43
pubmed: 26730835
J Gastrointest Surg. 2013 Sep;17(9):1689-97
pubmed: 23818123
Surg Endosc. 2008 Sep;22(9):1992-6
pubmed: 18568372
Aliment Pharmacol Ther. 2016 Aug;44(4):332-45
pubmed: 27302838
Am J Surg. 2016 May;211(5):877-85
pubmed: 27048945
Dis Colon Rectum. 2018 Dec;61(12):1372-1379
pubmed: 30312223
Cancer Manag Res. 2020 Aug 11;12:7151-7164
pubmed: 32848469
United European Gastroenterol J. 2019 Oct;7(8):1102-1112
pubmed: 31662867

Auteurs

Angela Dalia Ricci (AD)

Department of Experimental, Diagnostic and Specialty Medicine, Sant'Orsola-Malpighi University Hospital, ENETS Center of Excellence, 40138 Bologna, Italy.
Division of Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via P. Albertoni 15, 40138 Bologna, Italy.

Sara Pusceddu (S)

Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori Milano, ENETS Center of Excellence, 20133 Milan, Italy.

Francesco Panzuto (F)

Digestive Disease Unit, Sant'Andrea University Hospital, ENETS Center of Excellence of Rome, 00189 Rome, Italy.
Department of Medical Surgical Sciences and Translational Medicine, Sapienza University of Rome, 00189 Rome, Italy.

Fabio Gelsomino (F)

Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, 41125 Modena, Italy.

Sara Massironi (S)

Division of Gastroenterology, Department of Medicine and Surgery, University of Milano-Bicocca, San Gerardo School of Medicine, 20900 Monza, Italy.

Claudio Giovanni De Angelis (CG)

Department of Gastroenterology and Digestive Endoscopy, AOU Città della Salute e della Scienza, University of Turin, 10126 Turin, Italy.

Roberta Modica (R)

Endocrinology, Department of Clinical Medicine and Surgery, ENETS Center of Excellence, University "Federico II" of Naples, 80138 Naples, Italy.

Gianluca Ricco (G)

Department of Experimental, Diagnostic and Specialty Medicine, Sant'Orsola-Malpighi University Hospital, ENETS Center of Excellence, 40138 Bologna, Italy.
Division of Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via P. Albertoni 15, 40138 Bologna, Italy.

Martina Torchio (M)

Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori Milano, ENETS Center of Excellence, 20133 Milan, Italy.

Maria Rinzivillo (M)

Digestive Disease Unit, Sant'Andrea University Hospital, ENETS Center of Excellence of Rome, 00189 Rome, Italy.

Natalie Prinzi (N)

Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori Milano, ENETS Center of Excellence, 20133 Milan, Italy.

Felice Rizzi (F)

Department of Gastroenterology and Digestive Endoscopy, AOU Città della Salute e della Scienza, University of Turin, 10126 Turin, Italy.

Giuseppe Lamberti (G)

Department of Experimental, Diagnostic and Specialty Medicine, Sant'Orsola-Malpighi University Hospital, ENETS Center of Excellence, 40138 Bologna, Italy.
Division of Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via P. Albertoni 15, 40138 Bologna, Italy.

Davide Campana (D)

Department of Experimental, Diagnostic and Specialty Medicine, Sant'Orsola-Malpighi University Hospital, ENETS Center of Excellence, 40138 Bologna, Italy.
Division of Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via P. Albertoni 15, 40138 Bologna, Italy.

Classifications MeSH